ADMA Biologics, Inc. (NASDAQ:ADMA) Q1 2024 Earnings Conference Call May 9, 2024 4:30 AM ET
Company Participants
Skyler Bloom - Senior Director, Business Development and Corporate Strategy
Adam Grossman - President and CEO
Brian Lenz - Executive Vice President, Chief Financial Officer and General Manager, ADMA BioCenters
Conference Call Participants
Anthony Petrone - Mizuho Group
Kristen Kluska - Cantor Fitzgerald
Gary Nachman - Raymond James
Operator
Good afternoon, and welcome to the ADMA Biologics First Quarter 2024 Financial Results and Business Update Conference Call on Thursday, May 09, 2024. At this time, all participants are in a listen-only mode. There will be a question-and-answer session to follow. Please be advised that this call is being recorded at the company’s request and will be available on the company’s website approximately two hours following the end of the call.
At this time, I would like to introduce Skyler Bloom, Please go ahead.
Skyler Bloom
Welcome, everyone. And thank you for joining us this afternoon to discuss ADMA Biologics financial results for the fourth quarter and full year of 2023 and recent corporate updates. I’m joined today by Adam Grossman, President and Chief Executive Officer; and Brian Lenz, Executive Vice President, Chief Financial Officer and General Manager of ADMA BioCenters.
During today’s call, Adam will provide some introductory comments and provide us an update on corporate progress, and then Brian will provide an overview of the company’s first quarter 2024 financial results. Finally, Adam will then provide some brief summary remarks before opening up the call for your questions.
Earlier today, we issued a press release detailing the first quarter 2024 financial results and summarized certain achievements in recent corporate updates. The release is available on our website at www.admabiologics.com.
Before we begin our formal comments, I’ll remind you that we will be making forward-looking assertions during today’s call that represent the company’s intentions, expectations or beliefs concerning future events, which constitute forward-looking statements for the purposes of the Safe Harbor provisions under the Private Securities Litigation Reform Act of 1995.
All forward-looking statements are subject to factors, risks and uncertainties, such as those detailed in today’s press release announcing this call and in our filings with the SEC, which may cause actual results to differ materially from the results or implied by such statements.
In addition, any forward-looking statements represent our views as of the date of this call and should not be relied upon as representing our views as of the subsequent date. We specifically disclaim any obligation to update any such statements except as required by the federal securities laws.